中国P站

PCR; Real-time PCR; Digital PCR; Multiplex PCR; CRISPR/Cas; LAMP; Point-of-Care diagnostics; SARS-CoV-2; Cancer diagnostics; Pathogen detection; Microfluidics; RNA viruses

Introduction

The landscape of molecular diagnostics has seen transformative advancements, largely driven by innovations in Polymerase Chain Reaction (PCR) technologies. These developments are crucial for accurate and rapid detection across various fields, from infectious diseases to oncology. Early advancements include real-time PCR, which has significantly improved the speed and sensitivity for diagnosing pathogens like SARS-CoV-2, proving indispensable for effective pandemic management and informed clinical decisions. This technique represents a foundational methodological enhancement in infectious disease diagnostics [1].

Digital PCR (dPCR) emerged as a groundbreaking approach, offering absolute quantification of nucleic acids with unparalleled precision. This foundational principle extends its utility into diverse applications, including oncology, highly sensitive pathogen detection, and non-invasive prenatal testing. Both droplet-based and chip-based dPCR platforms demonstrate distinct advantages, expanding the capabilities of molecular quantification [2].

Beyond individual pathogen detection, multiplex PCR offers the capability to diagnose multiple infectious diseases concurrently from a single sample. This approach addresses the need for faster and more comprehensive diagnostics, particularly in clinical settings where syndromic infections require a broad, efficient screen. The continued exploration of design principles, challenges, and innovative solutions has expanded the practical utility of multiplex PCR significantly [3].

Further expanding the diagnostic toolkit are advanced methods like CRISPR/Cas-assisted PCR, which ingeniously merges the precision of CRISPR gene editing with the amplification power of PCR. This innovative synergy results in highly sensitive and specific nucleic acid detection methods. Such techniques offer distinct advantages over conventional PCR, especially for detecting low-abundance targets and minimizing the incidence of false positives, thereby enhancing diagnostic accuracy [4].

Loop-mediated Isothermal Amplification (LAMP) strategies present a compelling alternative to conventional PCR. LAMP provides rapid and cost-effective pathogen detection without requiring specialized thermal cyclers. This makes it particularly suitable for Point-of-Care diagnostics and surveillance programs in resource-limited settings, due to its accessibility and operational simplicity. The principles, primer design, and various detection methods associated with LAMP continue to be areas of active research and development [5].

The demand for rapid, accurate, and portable molecular diagnostic tools has led to significant progress in Point-of-Care (POC) PCR diagnostics. These innovations enable miniaturization, automation, and enhanced user-friendliness in PCR devices, making them deployable outside centralized laboratories. Such advancements are critical for ensuring timely clinical interventions and robust public health responses [6].

Reverse Transcription PCR (RT-PCR) remains an essential tool, particularly for detecting and characterizing RNA viruses. The evolution of RT-PCR from its early applications in viral discovery to its current widespread use in routine clinical diagnosis is remarkable, especially during outbreaks of emerging RNA viruses. Methodological variations continue to refine RT-PCR's inherent sensitivity and specificity, maintaining its critical role in virology [7].

Digital PCR (dPCR), specifically its Droplet Digital PCR (ddPCR) variant, has made a transformative impact on cancer diagnostics and monitoring. Its capacity for absolute quantification is uniquely suited for identifying rare mutations, tracking minimal residual disease, and analyzing circulating tumor DNA (ctDNA). This sophisticated technology provides a non-invasive and exceptionally sensitive method for personalized cancer management strategies [8].

In essence, next-generation PCR techniques are continuously evolving to deliver rapid and sensitive pathogen detection. These encompass advancements in real-time PCR, digital PCR, and other sophisticated amplification methods. The collective emphasis is on enhancing performance across speed, multiplexing capability, and detection limits, which are vital for effective control of infectious disease spread and broader applications in molecular diagnostics [9].

Finally, microfluidic PCR integrates miniaturization with PCR to create portable, efficient molecular diagnostic platforms. Microfluidic PCR benefits from miniaturization, reduced reagent consumption, and faster reaction times. This revolutionizes Point-of-Care testing by bringing sophisticated molecular diagnostics closer to the patient, an invaluable asset in remote areas or emergency situations [10].

The sum of these innovations underscores a dynamic field committed to improving diagnostic capabilities for global health.

Description

The field of molecular diagnostics is experiencing rapid evolution, driven by a continuous stream of innovations in Polymerase Chain Reaction (PCR) technologies. These advancements are not only improving existing methods but also introducing new paradigms for detecting nucleic acids, critical for disease diagnosis and fundamental research.

One area of significant progress is real-time PCR, which has become a cornerstone for rapid and accurate pathogen identification. Its application in diagnosing SARS-CoV-2 highlights improved sensitivity and speed, pivotal during the recent pandemic. These methodological enhancements underscore why real-time RT-PCR is an indispensable tool for infectious disease diagnostics and effective pandemic management [1]. Similarly, Reverse Transcription PCR (RT-PCR) is fundamental for detecting and characterizing RNA viruses. Its evolution from early viral discovery to widespread routine clinical diagnosis, especially during outbreaks, showcases its enduring importance. The inherent sensitivity and specificity of RT-PCR, continually refined, are central to its utility [7].

Digital PCR (dPCR) represents a leap forward by offering absolute quantification of nucleic acids with unparalleled precision. This technology is becoming invaluable across diverse medical fields, including oncology, pathogen detection, and non-invasive prenatal testing. Both droplet and chip-based dPCR platforms contribute to this versatility, each presenting unique benefits [2]. Building on this, Droplet Digital PCR (ddPCR) has specifically revolutionized cancer diagnostics and monitoring. Its ability to provide absolute quantification is well-suited for detecting rare mutations, monitoring minimal residual disease, and analyzing circulating tumor DNA (ctDNA). This provides a non-invasive, highly sensitive avenue for personalized cancer management [8].

The capability to detect multiple pathogens simultaneously from a single sample is now a reality thanks to recent advances in multiplex PCR. This innovation translates directly to faster and more comprehensive diagnostics in clinical settings, especially for identifying syndromic infections. Research continues to refine design principles and overcome challenges, expanding its diagnostic power [3].

Alternative amplification strategies, such as Loop-mediated Isothermal Amplification (LAMP), are also gaining traction. LAMP offers a rapid and cost-effective method for pathogen detection, without the need for complex thermal cyclers. This makes LAMP an excellent candidate for Point-of-Care diagnostics and surveillance programs, particularly in resource-limited environments. Understanding its principles, primer design, and detection methods is key to its broader implementation [5].

The integration of advanced technologies like CRISPR/Cas-assisted PCR signifies a new era of highly specific and sensitive nucleic acid detection. By combining CRISPR gene editing precision with PCR amplification power, these techniques offer distinct advantages over conventional PCR. They excel at detecting low-abundance targets and significantly minimize false positives, enhancing diagnostic reliability [4].

Furthermore, the drive towards accessible diagnostics has propelled Point-of-Care (POC) PCR diagnostics into the spotlight. The aim is to create rapid, accurate, and portable molecular diagnostic tools that function effectively outside traditional laboratories. Technological innovations in miniaturization, automation, and user-friendliness are making these POC PCR devices increasingly feasible, vital for quick clinical decisions and effective public health responses [6]. This push towards portability is further supported by microfluidic PCR, which integrates microfluidic technologies with PCR to yield efficient and compact diagnostic platforms. Benefits include miniaturization, reduced reagent consumption, and faster reaction times, transforming Point-of-Care testing, especially for remote or emergency situations [10].

Collectively, these next-generation PCR techniques are delivering unparalleled speed and sensitivity for pathogen detection. This includes the continuous evolution of real-time PCR, digital PCR, and other advanced amplification methods. The focus remains on enhancing overall performance in terms of speed, multiplexing capability, and detection limits, all essential for controlling infectious diseases and advancing molecular medicine [9].

Conclusion

Recent advancements across various PCR technologies are significantly enhancing diagnostics for infectious diseases and cancer. Real-time PCR has seen improvements in sensitivity and speed for SARS-CoV-2 diagnosis, making it essential for pandemic management. Digital PCR (dPCR), including droplet and chip-based platforms, offers unparalleled precision for nucleic acid quantification, proving valuable in oncology, pathogen detection, and prenatal testing. Multiplex PCR now allows simultaneous detection of multiple pathogens from a single sample, leading to faster and more comprehensive diagnostics for syndromic infections. CRISPR/Cas-assisted PCR combines CRISPR precision with PCR amplification for highly sensitive and specific nucleic acid detection, especially for low-abundance targets. Loop-mediated Isothermal Amplification (LAMP) provides a rapid, cost-effective alternative to traditional PCR, suitable for Point-of-Care diagnostics in resource-limited settings. Point-of-Care (POC) PCR diagnostics are also advancing, with innovations enabling miniaturization and automation for rapid, portable molecular tools outside centralized labs. Reverse Transcription PCR (RT-PCR) remains crucial for RNA virus detection, evolving from discovery to routine clinical diagnosis during outbreaks. Droplet Digital PCR (ddPCR) specifically offers transformative capabilities in cancer diagnostics, enabling absolute quantification for detecting rare mutations and monitoring minimal residual disease. Next-generation PCR techniques, encompassing real-time PCR, digital PCR, and other advanced methods, generally enhance speed, multiplexing, and detection limits for pathogen control. Finally, microfluidic PCR integrates miniaturization with PCR to create portable, efficient molecular diagnostic platforms, reducing reagent use and accelerating reaction times for Point-of-Care testing in remote or emergency scenarios.

References

1. Zi X, Jie Y, Hong W (2022) .J. Med. Virol. 94:2184-2195.

   , ,

2. Yuan C, Wenxin Z, Yiwen Y (2023) .Biosens. Bioelectron. 240:115456.

   , ,

3. Weilin Z, Xiaolong L, Qian Z (2021) .Front. Microbiol. 12:688126.

   , ,

4. Yaqiong M, Yanqing L, Chunyang L (2022) .Theranostics 12:2856-2870.

   , ,

5. Wenhui T, Weiwei C, Yujing Z (2023) .Front. Microbiol. 14:1118742.

   , ,

6. Young JP, Young EK, Kyung-Hwa L (2021) .J. Clin. Med. 10:5301.

   , ,

7. Debmalya B, Vasudha B, Rajan KS (2020) .Comput. Struct. Biotechnol. J. 18:2391-2401.

   , ,

8. Qianru J, Yafei L, Yongzheng L (2023) .Int. J. Mol. Sci. 24:8254.

   , ,

9. Jing G, Mengqian Z, Xiangfeng T (2022) .J. Microbiol. Methods 200:106488.

   , ,

10. Jaehoon K, Sangyeol L, Daehyeong K (2021) .Sensors 21:3390.

    , ,